I Dahlman1, I Sinha2, H Gao2, D Brodin2, A Thorell3, M Rydén1, D P Andersson1, J Henriksson4, A Perfilyev5, C Ling5, K Dahlman-Wright6, P Arner1. 1. Department of Medicine, Karolinska Institutet, Stockholm, Sweden. 2. Department of Biosciences and Nutrition, Karolinska Institutet, Stockholm, Sweden. 3. 1] Department of Clinical Sciences, Danderyds Hospital, Karolinska Institutet., Stockholm, Sweden [2] Department of Surgery, Ersta Hospital, Karolinska Institutet, Stockholm, Sweden. 4. 1] Department of Biosciences and Nutrition, Karolinska Institutet, Stockholm, Sweden [2] European Molecular Biology Laboratory, European Bioinformatics Institute, Wellcome Trust Genome Campus, Hinxton, UK. 5. Department of Clinical Sciences, Epigenetics and Diabetes, Lund University Diabetes Centre, CRC, Scania University Hospital, Malmo, Sweden. 6. 1] Department of Biosciences and Nutrition, Karolinska Institutet, Stockholm, Sweden [2] SciLifeLab, Science for Life Laboratory, Solna, Sweden.
Abstract
BACKGROUND/ OBJECTIVES: Obese subjects have increased number of enlarged fat cells that are reduced in size but not in number in post-obesity. We performed DNA methylation profiling in fat cells with the aim of identifying differentially methylated DNA sites (DMS) linked to adipose hyperplasia (many small fat cells) in post-obesity. SUBJECTS/ METHODS: Genome-wide DNA methylation was analyzed in abdominal subcutaneous fat cells from 16 women examined 2 years after gastric bypass surgery at a post-obese state (body mass index (BMI) 26±2 kg m(-2), mean±s.d.) and from 14 never-obese women (BMI 25±2 kg m(-2)). Gene expression was analyzed in subcutaneous adipose tissue from nine women in each group. In a secondary analysis, we examined DNA methylation and expression of adipogenesis genes in 15 and 11 obese women, respectively. RESULTS: The average degree of DNA methylation of all analyzed CpG sites was lower in fat cells from post-obese as compared with never-obese women (P=0.014). A total of 8504 CpG sites were differentially methylated in fat cells from post-obese versus never-obese women (false discovery rate 1%). DMS were under-represented in CpG islands and surrounding shores. The 8504 DMS mapped to 3717 unique genes; these genes were over-represented in cell differentiation pathways. Notably, 27% of the genes linked to adipogenesis (that is, 35 of 130) displayed DMS (adjusted P=10(-8)) in post-obese versus never-obese women. Next, we explored DNA methylation and expression of genes linked to adipogenesis in more detail in adipose tissue samples. DMS annotated to adipogenesis genes were not accompanied by differential gene expression in post-obese compared with never-obese women. In contrast, adipogenesis genes displayed differential DNA methylation accompanied by altered expression in obese women. CONCLUSIONS: Global CpG hypomethylation and over-representation of DMS in adipogenesis genes in fat cells may contribute to adipose hyperplasia in post-obese women.
BACKGROUND/ OBJECTIVES:Obese subjects have increased number of enlarged fat cells that are reduced in size but not in number in post-obesity. We performed DNA methylation profiling in fat cells with the aim of identifying differentially methylated DNA sites (DMS) linked to adipose hyperplasia (many small fat cells) in post-obesity. SUBJECTS/ METHODS: Genome-wide DNA methylation was analyzed in abdominal subcutaneous fat cells from 16 women examined 2 years after gastric bypass surgery at a post-obese state (body mass index (BMI) 26±2 kg m(-2), mean±s.d.) and from 14 never-obesewomen (BMI 25±2 kg m(-2)). Gene expression was analyzed in subcutaneous adipose tissue from nine women in each group. In a secondary analysis, we examined DNA methylation and expression of adipogenesis genes in 15 and 11 obesewomen, respectively. RESULTS: The average degree of DNA methylation of all analyzed CpG sites was lower in fat cells from post-obese as compared with never-obesewomen (P=0.014). A total of 8504 CpG sites were differentially methylated in fat cells from post-obese versus never-obesewomen (false discovery rate 1%). DMS were under-represented in CpG islands and surrounding shores. The 8504 DMS mapped to 3717 unique genes; these genes were over-represented in cell differentiation pathways. Notably, 27% of the genes linked to adipogenesis (that is, 35 of 130) displayed DMS (adjusted P=10(-8)) in post-obese versus never-obesewomen. Next, we explored DNA methylation and expression of genes linked to adipogenesis in more detail in adipose tissue samples. DMS annotated to adipogenesis genes were not accompanied by differential gene expression in post-obese compared with never-obesewomen. In contrast, adipogenesis genes displayed differential DNA methylation accompanied by altered expression in obesewomen. CONCLUSIONS: Global CpG hypomethylation and over-representation of DMS in adipogenesis genes in fat cells may contribute to adipose hyperplasia in post-obesewomen.
Authors: Maryline Olivier; Michael W Tanck; Ruud Out; Elise F Villard; Bart Lammers; Laura Bouchareychas; Eric Frisdal; Alexandre Superville; Theo Van Berkel; John J Kastelein; Miranda Van Eck; J Wouter Jukema; M John Chapman; Geesje M Dallinga-Thie; Maryse Guerin; Wilfried Le Goff Journal: Arterioscler Thromb Vasc Biol Date: 2012-07-05 Impact factor: 8.311
Authors: Lars Sjöström; Anna-Karin Lindroos; Markku Peltonen; Jarl Torgerson; Claude Bouchard; Björn Carlsson; Sven Dahlgren; Bo Larsson; Kristina Narbro; Carl David Sjöström; Marianne Sullivan; Hans Wedel Journal: N Engl J Med Date: 2004-12-23 Impact factor: 91.245
Authors: Michael G Borland; Prasad Krishnan; Christina Lee; Prajakta P Albrecht; Weiwei Shan; Moses T Bility; Craig B Marcus; Jyh M Lin; Shantu Amin; Frank J Gonzalez; Gary H Perdew; Jeffrey M Peters Journal: Carcinogenesis Date: 2014-03-17 Impact factor: 4.944
Authors: Jin Sun Jung; Min Ki Jee; Hyun Tae Cho; Jee In Choi; Young Bin Im; Oh Hyun Kwon; Soo Kyung Kang Journal: Cell Mol Life Sci Date: 2012-09-30 Impact factor: 9.261
Authors: Manish Tandon; Karthiga Gokul; Syed A Ali; Zujian Chen; Jane Lian; Gary S Stein; Jitesh Pratap Journal: Mol Cancer Date: 2012-06-18 Impact factor: 27.401
Authors: Erik Arner; Pål O Westermark; Kirsty L Spalding; Tom Britton; Mikael Rydén; Jonas Frisén; Samuel Bernard; Peter Arner Journal: Diabetes Date: 2009-10-21 Impact factor: 9.461
Authors: Yen-Tsung Huang; Su Chu; Eric B Loucks; Chien-Ling Lin; Charles B Eaton; Stephen L Buka; Karl T Kelsey Journal: Epigenetics Date: 2016-02-18 Impact factor: 4.528
Authors: Mohamed M Ali; Dina Naquiallah; Maryam Qureshi; Mohammed Imaduddin Mirza; Chandra Hassan; Mario Masrur; Francesco M Bianco; Patrice Frederick; Giulianotti P Cristoforo; Antonio Gangemi; Shane A Phillips; Abeer M Mahmoud Journal: Epigenetics Date: 2021-01-25 Impact factor: 4.528
Authors: Peter Arner; Indranil Sinha; Anders Thorell; Mikael Rydén; Karin Dahlman-Wright; Ingrid Dahlman Journal: Clin Epigenetics Date: 2015-09-08 Impact factor: 6.551
Authors: Ping Yu; Lexiang Ji; Kevin J Lee; Miao Yu; Chuan He; Suresh Ambati; Elizabeth C McKinney; Crystal Jackson; Clifton A Baile; Robert J Schmitz; Richard B Meagher Journal: PLoS One Date: 2016-05-12 Impact factor: 3.240